Dr Benjamin Goudey
AI Technical Lead, Australian Biocommons
Australian Biocommons
83 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Sex and APOE ε4 genotype modify risk factor associations with cerebral amyloid angiopathy: a multi-cohort autopsy study
DOI: 10.1186/s13195-025-01948-82025
Journal article
Public Health
DOI: 10.1002/alz70860_0971062025
Journal article
Proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial processes between human and mouse ALS models
DOI: 10.1038/s41598-025-11466-02025
Journal article
Development and validation of an interpretable clinical scoring model to monitor the progression of preclinical Alzheimer’s disease
DOI: 10.1186/s13195-025-01931-32025
Journal article
Predicting severity of cerebral amyloid angiopathy neuropathology: A modeling approach using NACC and ROSMAP data
DOI: 10.1002/alz.700572025
Conference Proceedings
Analytics of HLA-DQ association in lichen planus
DOI: 10.1016/j.humimm.2025.1113722025
Journal article
A survey on deep learning for polygenic risk scores
DOI: 10.1093/bib/bbaf373
RECENT SCHOLARLY WORKS
2025
Journal article
Development and validation of a model to predict the progression of Alzheimer's disease
DOI: 10.1093/ageing/afaf1982025
Journal article
Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity
DOI: 10.1002/alz.145832025
Journal article
Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's disease
DOI: 10.1002/alz.14602